Tianeptine: paradoxical mechanism and pharmacokinetics
Tianeptinum stands out among psychotropic drugs for its unique pharmacodynamic profile. Its specific action lies in the fact that it enhances (stimulates) neuronal serotonin reuptake in the cerebral cortex and hippocampus. This mechanism is directly opposite to the action of classical reuptake inhibitors. At the same time, the drug's effect on dopamine and noradrenaline metabolism remains weak.
The pharmacokinetic parameters of tianeptine ensure its high bioavailability (up to 99%) due to rapid and complete absorption from the gastrointestinal tract. In the blood, the drug is actively bound to plasma proteins—at 94%. Metabolism is carried out through β-oxidation and N-demethylation. The half-life is relatively short at 2.5 hours, though in elderly patients it is prolonged up to 3.5 hours. Elimination occurs via the kidneys: predominantly as metabolites, with only 8% of the substance excreted unchanged.
Clinical effects and safety of tianeptine
The drug successfully combines antidepressant action with a pronounced anxiolytic (anti-anxiety) effect. In clinical practice, it normalizes behavior and mood, restores physiological sleep, improves concentration, and effectively reduces somatic symptoms of depression.
Main indications for prescription include:
- Reactive and neurotic depression.
- Anxiety-depressive states accompanied by somatic complaints.
- Depressive disorders against the background of chronic alcoholism.
The safety profile of tianeptine is considered highly favorable. The drug does not cause addiction, does not suppress libido, and has no negative impact on memory. Side effects occur relatively infrequently and are not life-threatening. Among them may be gastrointestinal disturbances (dry mouth, epigastric pain, nausea, vomiting, constipation, flatulence, anorexia), CNS effects (insomnia or drowsiness, tremor, asthenia, dizziness, headache), and cardiovascular effects (tachycardia, extrasystole, chest pain). In rare cases, patients complain of muscle pain, lower back pain, or difficulty breathing.
Mirtazapine: receptor profile and mechanism of action
Mirtazapinum is a representative of the tetracyclic antidepressants group. Its main pharmacological effect is based on the blockade of presynaptic α2-adrenergic receptors located in serotonergic and adrenergic synapses. By blocking these receptors, the drug causes a powerful increase in the release of neurotransmitters—serotonin and noradrenaline—from nerve endings.
In addition to its main mechanism, mirtazapine possesses several additional effects due to its affinity for other types of receptors:
- Pronounced sedative action, which occurs due to the blockade of H1-histamine receptors.
- Weak blockade of peripheral α1-adrenergic receptors.
- Insignificant blockade of cholinergic receptors.
Application and risks of mirtazapine therapy
In clinical practice, mirtazapine is used primarily for the treatment of endogenous depressions, as well as conditions accompanied by pronounced psychomotor retardation. In its therapeutic efficacy, it surpasses traditional tricyclic antidepressants. It is important to consider that the clinical effect does not develop immediately, but after 1–2 weeks of regular administration.
Despite its high efficacy, mirtazapine therapy is associated with a number of specific adverse events:
- Metabolic disorders: increased appetite and weight gain are frequently observed.
- Neurological and psychiatric reactions: muscle twitching, apathy, and excessive sedation are possible.
- Cardiovascular reactions: orthostatic hypotension (explained by α2-adrenergic receptor blockade).
- Hematological complications: rare, but clinically significant conditions such as leukopenia and agranulocytosis.
Furthermore, upon discontinuation of the drug, there is a risk of withdrawal syndrome.
To remember the paradoxical action of tianeptine: Tianeptine tulls (pulls back) serotonin. Unlike most antidepressants, it does not block, but specifically stimulates the reuptake of the neurotransmitter by neurons.
Class and exam questions
What is the main feature of tianeptine's mechanism of action?
It has a paradoxical effect: it does not inhibit, but stimulates neuronal serotonin reuptake in the cerebral cortex and hippocampus.
How quickly does the effect of mirtazapine appear?
The clinically significant antidepressant effect develops not immediately, but 1–2 weeks after the start of therapy.
Does tianeptine cause dependence or a decline in cognitive functions?
No, the drug has a favorable safety profile: it is not habit-forming and has no negative effect on memory.
Why does mirtazapine cause severe drowsiness?
The pronounced sedative effect of this drug is due to its ability to block H1-histamine receptors.
What else to study on this topic
- Pharmacokinetics of tianeptine: processes of β-oxidation and N-demethylation.
- Hematological complications of mirtazapine: risks of developing agranulocytosis and leukopenia.
- Comparative efficacy of mirtazapine and tricyclic antidepressants.
- Withdrawal syndrome in therapy with tetracyclic antidepressants.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Atypical antidepressants" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.